Desktop Genetics competitorsClear all

Desktop Genetics's top competitors include PetaGene, Envisagenics, GrAI Matter Labs and BenevolentAI.
Desktop Genetics
Desktop Genetics
Desktop Genetics develops a platform for scientists to build and share DNA molecules.
PetaGene
PetaGene
PetaGene develops genomics data compression and acceleration software.
Envisagenics
Envisagenics
Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies.
GrAI Matter Labs
GrAI Matter Labs
GrAI Matter Labs utilizes biology-inspired spiking neural networks to overcome the limitations of traditional Von Neumann machines and application processors.
BenevolentAI
BenevolentAI
BenevolentAI is a company engaged in the development and application of artificial intelligence for drug discovery and development.
Founding Date
Founding Date
2012
Founding Date
2015
Founding Date
2014
Founding Date
2016
Founding Date
2013
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
London, GB HQ
Cambridge, US
Locations
Cambridge, GB HQ
Cambridge, GB
Locations
New York, US HQ
New York, US
Locations
Paris, FR HQ
Eindhoven, NL
San Jose, US
Locations
London, GB HQ
Babraham, GB
Brooklyn, US
Employees
Employees
1
Employees
10
Employees
1711% decrease
Employees
502% increase
Employees
2725% increase
Twitter followers
Twitter followers
3.6 k
Twitter followers
142
Twitter followers
931
Twitter followers
N/A
Twitter followers
6.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
62
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.7
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
93.55%
Alexa Website Rank
Alexa Website Rank
791111
Alexa Website Rank
409607
Alexa Website Rank
366320
Alexa Website Rank
224689
Alexa Website Rank
280386
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
5
Employee Rating
N/A
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
£382.8k (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£6.8m (FY, 2018)
Net income
Net income
(£229.8k) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
(£26.9m) (FY, 2018)

Funding

Latest funding round
Latest funding round
$ 1.7m (11 months ago)
Latest funding round
$ 2.1m (almost 2 years ago)
Latest funding round
$ 2.4m (almost 3 years ago)
Latest funding round
$ 15m (over 2 years ago)
Latest funding round
$ 90m (about 1 year ago)
Total funding raised
Total funding raised
$ 7.3m
Total funding raised
$ 2.4m
Total funding raised
$ 3.1m
Total funding raised
$ 15m
Total funding raised
$ 305m
For sources of this data, please see the company profile

View company profiles

PetaGene
HQ
Cambridge, GB
Employees
10

PetaGene develops genomics data compression and acceleration software.

View company
Envisagenics
HQ
New York, US
Employees
17↓ 11% decrease

Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies.

View company
GrAI Matter Labs
HQ
Paris, FR
Employees
50↑ 2% increase

GrAI Matter Labs utilizes biology-inspired spiking neural networks to overcome the limitations of traditional Von Neumann machines and application processors.

View company
BenevolentAI
HQ
London, GB
Employees
272↑ 5% increase

BenevolentAI is a company engaged in the development and application of artificial intelligence for drug discovery and development.

View company